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BACKGROUND
 Peripheral intravenous catheter (PIVC) is  the 
most commonly invasive clinical procedure 
that performed in hospital worldwide.
 The insertion of PIVC has become the most 
common invasive procedure performed to 
patients in hospital which aims to infuse fluids, 
administering IV medication, transfuse blood 
products, and deliver nutrients to patients (Ho
& Cheung, 2012; Tee, Siew, Low, & Matizha, 
2015)
 However, this procedure usually fails before the end of therapy due to 
many complications either local or systemic, such as phlebitis, 
extravasations, infiltration, hematoma, infection and embolism (Wallis et 
al., 2014). One of the most complications occurred is phlebitis (Abdul-hak
& Barros, 2012).
 These complications can ccontribute to increase morbidity, increased 
mortality, and prolonged hospitalization (Kagel 2004). 
BACKGROUND
 The incidence of phlebitis varies from 1.3% to 61.2%. 
 18.9% phlebitis developed from 952 PIVCs assessed in adults 
(Gonzales, 2014). 
 In a study conducted in Turkey, 439 catheters inserted in 103 
adult patients, the occurrence of phlebitis was 41.2% (Pasalioglu
& Kaya, 2014). 
BACKGROUND
WHAT IS PHLEBITIS?
 Phlebitis is an inflammation at wall of vein with sign and 
symptoms of pain, erythema, warmth, swelling, along the site of 
PIVC insertion. 
 Phlebitis may be localized to the insertion site or travel along the 
vein. 
 Phlebitis may occur during catheterization or up to 48 hours after 
removal 7.
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 High incidence of phlebitis contributes factors such are; dwell 
time of PIVC (Abdul-hak & Barros, 2012; Danski, Oliveira, 
Johann, Pedrolo, & Vayego, 2015; Saini, Agnihotri, Gupta, & 
Walia, 2011)
 Anatomy of site of PIVC insertion, place of catheter insertion, 
such as in emergency department, presence of medication as 
infusate, gender, type of infusion, presence of chronic disease, 
and presence of infection (Maria et al., 2016; 2012; Ghorbani, 
2007). 
 In Malaysia, there are lack of study regarding phlebitis and its 
risk factors being identified. 
OBJECTIVES
 To determine the incidence of phlebitis among patients with 
PIVC
 To evaluate the significant risk factors associated with incidence 
of phlebitis among patients with PIVC. 
METHODS
Design
• Observational study
Participant
• patients who had PIVC
Setting
• 793 beds hospital
• Hospital Tengku Ampuan Afzan, Kuantan, Pahang
• From September 2016 to January 2017
INSTRUMENTS
Visual Infusion Phlebitis (VIP) score checklist adopted from Royal College of 
Nursing (2010) 
This checklist consists of;
i. Part A : Sociodemographic data 
ii. Part B : history of phlebitis, time of PIVC insertion, duration of PIVC 
replacement, site of PIVC, size, type of medication and fluid, type of 
flushing, presence of chronic disease, place the PIVC inserted, type of 
dressing plaster, and type of admission. 
RESULTS
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Significant Risk Factors Associated With Incidence Of Phlebitis 
Among Patients With PIVC. 
Characteristic  Frequency  Phlebitis (N=52)  
  Yes No p value 
 N (%) N (%) N (%)  
Present of chronic disease       p<0.05 
Yes 65 40.4 33 20.5 32 19.9  
No 96 59.6 19 11.8 77 47.8  
History of phlebitis       p<0.05 
Yes 30 18.6 16 9.9 14 8.7  
No 90 55.9 17 10.6 73 45.3  
Unknown 41 25.5 19 11.8 22 13.7  
Type of IV medication       p=0.43 
Antibiotic 32 19.9 11 6.8 21 13.0  
Other medication 40 24.8 12 7.5 28 17.4  
Antibiotic and other 
medication 
57 35.4 22 13.7 35 21.7  
No medication 32 19.9 7 4.3 25 15.5  
Size       p=0.85 
14 1 0.6 - - 1 0.6  
16 3 1.9 1 0.6 2 1.2  
18 73 45.3 26 16.1 47 29.2  
20 79 49.1 23 14.3 56 34.8  
22 5 3.1 2 1.2 3 1.9  
Insertion in       p=0.57 
Emergency 99 61.5 30 18.6 69 42.9  
Ward 56 38.4 20 12.4 36 22.4  
Operation theatre 2 1.2 - - 2 1.2  
Clinic 4 2.5 2 1.2 2 1.2  
	
DISCUSSION
 The incidence of phlebitis, 32.2% was similar with a study by 
(Maria et al., 2016) with incidence rate of phlebitis 31.1%.
 However it is lower than findings in study by Uslusoy & Mete, 
(2008), 43% and do Rego Furtado, (2011), 54.5%. 
 This variation of incidence of phlebitis, maybe due to different 
definition of phlebitis from different study, different type of 
population, and method. 
DISCUSSION
 Presence of chronic disease was associated with incidence of phlebitis 
with p value<0.05 
 The presence of chronic disease such as diabetes mellitus and infectious 
disease gave significant association to the development of phlebitis 
(Ghorbani, 2007). 
 The result of study by Karina et al., (2014) also gave similar result, which 
discovered that patients with chronic disease were high chance to get 
phlebitis statistically. 
 A review by Dychter, Gold, Carson, & Haller (2012) also mentioned that 
existence of chronic disease such as diabetes mellitus, and hypertension  
among patients with PIVC associated with occurrence of phlebitis and 
consequently lead to infection. 
 Patient with history of phlebitis gave significant result on incidence of 
phlebitis (p<0.05), and this result in agreement with a study by Webster 
et al., (2008) which found significant association between history of 
phlebitis and development of phlebitis. 
CONCLUSION
 Overall, phlebitis was the most frequent reason of PIVC removal and 
complication in this study. 
 This high incidence from the result indicated a worrying outcome, as 
it is greater than the percentage recommended by INS (2011). 
 This study demonstrated that patients with chronic disease and 
history of phlebitis were most likely to develop phlebitis. 
 Thus it is suggested that a specific guideline on insertion and care of 
PIVC to be created for these kinds of patients which may help in 
reduce more incidence of phlebitis. 
 Moreover, further study within the same scope need to be carried out 
to provide new data to serve as indicators to assist the achievement 
of improvements in PIVC care performance.

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